Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 03, 2023

Outcomes of ctDNA Analysis in Patients With HR+/HER2− Advanced Breast Cancer Treated With Ribociclib Plus Endocrine Therapy

Annals of Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Oncology
Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials
Ann. Oncol 2023 Sep 04;[EPub Ahead of Print], F André, F Su, N Solovieff, G Hortobagyi, S Chia, P Neven, A Bardia, D Tripathy, YS Lu, A Lteif, T Taran, N Babbar, D Slamon, CL Arteaga

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading